+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Cell Type, End User, and Geography

  • ID: 5322289
  • Report
  • April 2021
  • Region: Global
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • Catalent Inc
  • Corning Incorporated
  • Cytiva
  • Fresenius Kabi AG
  • Lonza
  • MORE
The global cell therapy bioprocessing market is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.14% from 2020 to 2028. Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat chronic and rare diseases.



Cell and gene therapy is still in an early stage of development in the biotechnology sector. Despite of being niche domain of the biotechnology sector, cell and gene therapy have paved the investments by the contract development and manufacturing organizations (CDMO)/contract manufacturing organizations (CMO). Companies are investing to enhance their manufacturing capabilities and offer world-class therapies to treat chronic conditions. Companies are adopting inorganic and organic strategies such as acquisitions and expansion to broaden their cell and gene therapy segment.

Recently, there have been a few instances of companies investing a huge amount to enter in the cell and gene therapy segment. For instance, in February 2020, Catalent, Inc. and MaSTherCell Global, Inc. have signed an agreement, in which Catalent, Inc. has agreed to acquire MaSTherCell Global, Inc. for an amount of US$ 135 million. It is stated that Catalent, Inc. is in a good state to merge with MaSTherCell Global, Inc.’s capabilities and R&D resources to build its own development and commercial manufacturing facilities.

Similarly, in February 2021, Rentschler Biopharma, a German-based CDMO has expanded its manufacturing capabilities at Cell and Gene Therapy (CGT) Catapult in the UK. Rentschler Biopharma is looking forward to entering the regenerative medicine segment and initiate the production of adeno-associated virus (AAV) vector for cell and gene therapies. Rentschler Biopharma is likely to invest an undisclosed amount over the five years and will share its expertise and capabilities with CGT Catapult.

Such instances of investments are expected to boost the sector and enhance the cell therapy bioprocessing in the coming future. Additionally, in the last few years, there has been significant investments done by the biopharmaceutical companies in the cell and gene therapy segment. According to the Alliance for Regenerative Medicine (ARM), investments in the cell and gene therapy has doubled in 2020 compared to 2019 and considerably higher than 2018. Companies across the world have invested US$ 19.9 billion in 2020, whereas the investments were accounted for US$ 13.5 billion in 2018 and US$ 9.8 billion in 2019. Thus, owing to the heavy investments, the market is expected to be flourishing in the coming years.

The cell therapy bioprocessing market, by technology, is segmented into bioreactor, lyophilization, electro spinning, controlflow centrifugation, ultrasonic lysis, genome editing technology, cell immortalization technology, and viral vector technology. The Bioreactor segment held the largest share of the market in 2020, whereas the genome editing technology segment is anticipated to register the highest CAGR of 14.5% in the market during the forecast period.

The cell therapy bioprocessing market, by cell type, is segmented into stem cell, immune cell, human embryonic stem cell, pluripotent stem cell, hematopoietic stem cells. The stem cell segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 14.0% in the market during the forecast period.

The cell therapy bioprocessing market, by indication, is segmented cardiovascular disease (CVD), oncology, wound healing, orthopedic, and others. The oncology segment held the largest share of the market in 2020, and the orthopedic segment is anticipated to register the highest CAGR of 14.3% in the market during the forecast period.

The Central Drugs Standard Control Organization, Commission for Protection against Health Risks, Contract Research Organizations, and Drug Safety and Effectiveness Network are among the major secondary sources referred to while preparing the report on the cell therapy bioprocessing market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • Catalent Inc
  • Corning Incorporated
  • Cytiva
  • Fresenius Kabi AG
  • Lonza
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell Therapy Bioprocessing Market - By Technology
1.3.2 Cell Therapy Bioprocessing Market - By Cell Type
1.3.3 Cell Therapy Bioprocessing Market - By Indication
1.3.4 Cell Therapy Bioprocessing Market - By End User
1.3.5 Cell Therapy Bioprocessing Market- By Geography

2. Cell Therapy Bioprocessing Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cell Therapy Bioprocessing Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Cell Therapy Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Investments for Cell and Gene Therapy Manufacturing
5.1.2 Growing Approvals for Cell Therapies
5.2 Market Restraints
5.2.1 Challenges Associated with Cell Therapy Bioprocessing
5.3 Market Opportunities
5.3.1 Automated Procedures to Produce Cell Therapies
5.4 Future Trends
5.4.1 Digital Biomanufacturing
5.5 Impact Analysis

6. Cell Therapy Bioprocessing Market- Global Analysis
6.1 Global Cell Therapy Bioprocessing Market Revenue Forecast and Analysis
6.2 Global Cell Therapy Bioprocessing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Cell Therapy Bioprocessing Market Analysis - By Technology
7.1 Overview
7.2 Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
7.3 Bioreactor
7.3.1 Overview
7.3.2 Bioreactor: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Lyophilization
7.4.1 Overview
7.4.2 Lyophilization: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Electrospinning
7.5.1 Overview
7.5.2 Electrospinning: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Controlflow Centrifugation
7.6.1 Overview
7.6.2 Controlflow Centrifugation: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.7 Ultrasonic Lysis
7.7.1 Overview
7.7.2 Ultrasonic Lysis: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.8 Genome Editing Technology
7.8.1.1 Overview
7.8.2 Genome Editing Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.9 Cell Immortalization Technology
7.9.1 Overview
7.9.2 Cell Immortalization Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
7.10 Viral Vector Technology
7.10.1.1 Overview
7.10.2 Viral Vector Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)

8. Cell Therapy Bioprocessing Market Analysis - By Cell Type
8.1 Overview
8.2 Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
8.3 Stem Cell
8.3.1 Overview
8.3.2 Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Immune Cell
8.4.1 Overview
8.4.2 Immune Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Human Embryonic Stem Cell
8.5.1 Overview
8.5.2 Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Pluripotent Stem Cell
8.6.1 Overview
8.6.2 Pluripotent Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
8.7 Hematopoietic Stem Cell
8.7.1 Overview
8.7.2 Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)

9. Cell Therapy Bioprocessing Market Analysis - By Indication
9.1 Overview
9.2 Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
9.3 Cardiovascular Disease (CVD)
9.3.1 Overview
9.3.2 Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Wound Healing
9.5.1 Overview
9.5.2 Wound Healing: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopedic
9.6.1 Overview
9.6.2 Orthopedic: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)

10. Cell Therapy Bioprocessing Market- By End User
10.1 Overview
10.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Centres
10.4.1 Overview
10.4.2 Diagnostic Centres: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
10.5 Regenerative Medicine Centres
10.5.1 Overview
10.5.2 Regenerative Medicine Centers: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
10.6 Academic and Research Institute
10.6.1 Overview
10.6.2 Academic and Research Institute: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)

11. Cell Therapy Bioprocessing Market - Geographical Analysis
11.1 North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 North America: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.1.4 North America: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.1.5 North America: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.1.6 North America: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.1.7 North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.1.8 US: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1 US: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.2 US: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.1.8.3 US: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.1.8.4 US: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.1.8.5 US: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.1.9 Canada: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.1 Canada: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.2 Canada: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.1.9.3 Canada: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.1.9.4 Canada: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.1.9.5 Canada: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.1.10 Mexico: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.1 Mexico: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.2 Mexico: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.1.10.3 Mexico: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.1.10.4 Mexico: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.1.10.5 Mexico: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2 Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.2.1 Overview
11.2.2 Europe: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.4 Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.5 Europe: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.6 Europe: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.7 Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.2.8 Germany: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.1 Germany: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.2 Germany: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.8.3 Germany: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.8.4 Germany: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.8.5 Germany: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.9 UK: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.9.1 UK: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.9.2 UK: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.9.3 UK: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.9.4 UK: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.9.5 UK: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.10 France: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.10.1 France: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.10.2 France: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.10.3 France: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.10.4 France: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.10.5 France: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.11 Spain: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.11.1 Spain: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.11.2 Spain: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.11.3 Spain: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.11.4 Spain: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.11.5 Spain: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.12 Italy: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.12.1 Italy: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.12.2 Italy: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.12.3 Italy: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.12.4 Italy: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.12.5 Italy: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.2.13 Rest of Europe: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.13.1 Rest of Europe: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.2.13.2 Rest of Europe: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.2.13.3 Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.2.13.4 Rest of Europe: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.2.13.5 Rest of Europe: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3 Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.3.1 Overview
11.3.2 Asia Pacific: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.5 Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.7 Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.3.8 China: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.1 China: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.2 China: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.8.3 China: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.8.4 China: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.8.5 China: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.9 Japan: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.9.1 Japan: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.9.2 Japan: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.9.3 Japan: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.9.4 Japan: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.9.5 Japan: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.10 India: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.10.1 India: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.10.2 India: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.10.3 India: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.10.4 India: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.10.5 India: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.11 South Korea: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.11.1 South Korea: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.11.2 South Korea: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.11.3 South Korea: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.11.4 South Korea: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.11.5 South Korea: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.12 Australia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.12.1 Australia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.12.2 Australia: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.12.3 Australia: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.12.4 Australia: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.12.5 Australia: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.3.13 Rest of Asia Pacific: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.13.1 Rest of Asia Pacific: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.3.13.2 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.3.13.3 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.3.13.4 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.3.13.5 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.4 Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.4.1 Overview
11.4.2 Middle East & Africa: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.4.4 Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.4.5 Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.4.6 Middle East & Africa: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.4.7 Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.4.8 UAE: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.1 UAE: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.2 UAE: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.4.8.3 UAE: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.4.8.4 UAE: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.4.8.5 UAE: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.4.9 Saudi Arabia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.9.1 Saudi Arabia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.9.2 Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.4.9.3 Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.4.9.4 Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.4.9.5 Saudi Arabia: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.4.10 South Africa: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.10.1 South Africa: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.10.2 South Africa: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.4.10.3 South Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.4.10.4 South Africa: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.4.10.5 South Africa: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.4.11 Rest of MEA: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.11.1 Rest of MEA: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.4.11.2 Rest of MEA: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.4.11.3 Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.4.11.4 Rest of MEA: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.4.11.5 Rest of MEA: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.5 South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.5.1 Overview
11.5.2 South and Central America: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.5.4 South and Central America: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.5.5 South and Central America: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.5.6 South and Central America: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.5.7 South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.5.8 Brazil: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.8.1 Brazil: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.8.2 Brazil: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.5.8.3 Brazil: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.5.8.4 Brazil: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.5.8.5 Brazil: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.5.9 Argentina: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.9.1 Argentina: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.9.2 Argentina: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.5.9.3 Argentina: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.5.9.4 Argentina: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.5.9.5 Argentina: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)
11.5.10 Rest of SCAM: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.10.1 Rest of SCAM: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
11.5.10.2 Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology, 2019-2028 (USD Million)
11.5.10.3 Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type, 2019-2028 (USD Million)
11.5.10.4 Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication, 2019-2028 (USD Million)
11.5.10.5 Rest of SCAM: Cell Therapy Bioprocessing Market, by End User, 2019-2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Global Cell Therapy Bioprocessing Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Cell Therapy Bioprocessing Market-Industry Landscape
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview

14. Company Profiles
14.1 Fresenius Kabi AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Asahi Kasei Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERCK KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 THERMO FISHER SCIENTIFIC INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Corning Incorporated
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Cytiva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lonza
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms


List of Tables
Table 1. North America: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 6. US: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 7. US: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 8. US: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 19. Europe: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 20. Europe: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 23. Germany: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 24. Germany: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 26. UK: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 27. UK: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 28. UK: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 29. France: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 30. France: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 31. France: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 32. France: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 33. Spain: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 34. Spain: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 35. Spain: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 36. Spain: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Italy: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 38. Italy: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 39. Italy: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 40. Italy: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 49. China: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 50. China: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 51. China: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 52. China: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 54. Japan: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 57. India: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 58. India: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 59. India: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 60. India: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 61. South Korea: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 62. South Korea: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 63. South Korea: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 64. South Korea: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 65. Australia: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 66. Australia: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 67. Australia: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 68. Australia: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 77. UAE: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 78. UAE: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 79. UAE: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 80. UAE: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 81. Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 82. Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 83. Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 84. Saudi Arabia: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 88. South Africa: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of MEA: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of MEA: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of MEA: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 96. South and Central America: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 100. Brazil: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 104. Argentina: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type - Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of SCAM: Cell Therapy Bioprocessing Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Cell Therapy Bioprocessing Market

List of Figures
Figure 1. Cell Therapy Bioprocessing Market Segmentation
Figure 2. Cell Therapy Bioprocessing Segmentation, By Region
Figure 3. Global Cell Therapy Bioprocessing Market Overview
Figure 4. Bioreactor Held Largest Share of Technology Segment in Cell Therapy Bioprocessing Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Cell Therapy Bioprocessing Market, by Geography (US$ Million)
Figure 7. Global Cell Therapy Bioprocessing Market- Leading Country Markets (US$ Million)
Figure 8. Global Cell Therapy Bioprocessing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Cell Therapy Bioprocessing Market Impact Analysis of Drivers and Restraints
Figure 16. Global Cell Therapy Bioprocessing Market- Revenue Forecast and Analysis - 2020- 2028
Figure 17. Global Cell Therapy Bioprocessing Market- By Geography Forecast and Analysis - 2020- 2028
Figure 18. Market Positioning of Key Players in Global Cell Therapy Bioprocessing Market
Figure 19. Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
Figure 20. Bioreactor: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Lyophilization: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Electrodspinning: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Controlflow Centrifugation: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Ultrasonic Lysis: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. Genome Editing Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cell Immortalization Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 27. Viral Vector Technology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 28. Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
Figure 29. Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 30. Immune Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 31. Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 32. Pluripotent Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 33. Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 34. Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
Figure 35. Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 36. Oncology: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 37. Wound Healing: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 38. Orthopedic: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 39. Others: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 40. 8.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
Figure 41. Hospitals and Clinics: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 42. Diagnostic Centres: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 43. Regenerative Medicine Centers: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 44. Academic and Research Institute: Cell Therapy Bioprocessing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 45. North America: Cell Therapy Bioprocessing Market, by Key Country - Revenue (2020) (USD Million)
Figure 46. North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)
Figure 47. North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 48. US: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Canada: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Mexico: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Cell Therapy Bioprocessing Market, by Key Country - Revenue (2020) (USD Million)
Figure 52. Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 54. Germany: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. UK: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. France: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Spain: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 58. Italy: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Europe: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia Pacific: Cell Therapy Bioprocessing Market, by Key Country - Revenue (2020) (USD Million)
Figure 61. Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)
Figure 62. Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 63. China: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 64. Japan: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 65. India: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. South Korea: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 67. Australia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Asia Pacific: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. Middle East & Africa: Cell Therapy Bioprocessing Market, by Key Country - Revenue (2020) (USD Million)
Figure 70. Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)
Figure 71. Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 72. UAE: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Saudi Arabia: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. South Africa: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of MEA: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Cell Therapy Bioprocessing Market, by Key Country - Revenue (2020) (USD Million)
Figure 77. South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)
Figure 78. South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 79. Brazil: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 80. Argentina: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 81. Rest of SCAM: Cell Therapy Bioprocessing Market - Revenue and Forecast to 2028 (USD Million)
Figure 82. Impact of COVID-19 Pandemic in North American Country Markets
Figure 83. Impact of COVID-19 Pandemic in European Country Markets
Figure 84. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 85. Impact of COVID-19 Pandemic in Middle East & Africa Market
Figure 86. Impact of COVID-19 Pandemic in South & Central America Market
Figure 87. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Fresenius Kabi AG
  • Asahi Kasei Corporation
  • Sartorius AG
  • MERCK KGaA
  • THERMO FISHER SCIENTIFIC INC.
  • Corning Incorporated
  • Cytiva
  • Lonza
  • Repligen
  • Catalent Inc
Note: Product cover images may vary from those shown
Adroll
adroll